Brian T. Feeley, MD, FAAOS, was bestowed with the 2025 Kappa Delta Elizabeth Winston Lanier Award for his research in ...
The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...